Key Messages
Complete molecular remission in ‘variant APL’ patient with short isoform of PML-RARα and FLT3-ITD in response to ATRA and ATO plus IDA. The use of FLT3 inhibitor in APL induction management could prevent differentiation syndrome and coagulopathy experienced in the patient.